Anne Klibanski, MD [clinicaltrials_resource:2b6b64ba3a3aaa5f4565e4255c59f457]
clinicaltrials:NCT00088153clinicaltrials:NCT00140842clinicaltrials:NCT00182091clinicaltrials:NCT00283595The Effect of Testosterone Replacement on Bone Mineral Density in Boys and Men With Anorexia Nervosa [clinicaltrials:NCT00853502]Long-term Cardiovascular Risk in Cured Cushing's Patients [clinicaltrials:NCT00881283]clinicaltrials:NCT01121211clinicaltrials:NCT01301183IGF-1 and Bone Loss in Women With Anorexia Nervosa [clinicaltrials:NCT01406444]Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa [clinicaltrials:NCT01642550]
overall official [clinicaltrials_vocabulary:overall-official]
Anne Klibanski, MD [clinicaltrials_resource:2b6b64ba3a3aaa5f4565e4255c59f457]
Bio2RDF identifier
2b6b64ba3a3aaa5f4565e4255c59f457
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2b6b64ba3a3aaa5f4565e4255c59f457
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
STULSIANI@MGH.HARVARD.EDU
aklibanski@partners.org
emeenaghan@partners.org
mmisra@partners.org
last name [clinicaltrials_vocabulary:last-name]
Anne Klibanski, MD
phone [clinicaltrials_vocabulary:phone]
617-643-0266
617-724-5602
617-724-7393
617-726-3870
role [clinicaltrials_vocabulary:role]
Principal Investigator
identifier
clinicaltrials_resource:2b6b64ba3a3aaa5f4565e4255c59f457
title
Anne Klibanski, MD
@en
type
label
Anne Klibanski, MD [clinicaltrials_resource:2b6b64ba3a3aaa5f4565e4255c59f457]
@en